We are live on ! Find out more
National Bank of Canada

National Bank of Canada Portfolio holdings

AUM $112B
1-Year Est. Return 31.26%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+31.26%
3 Year Est. Return
+84.25%
5 Year Est. Return
10 Year Est. Return
AUM
$112B
AUM Growth
+$1.53B
Cap. Flow
+$1.78B
Cap. Flow %
1.6%
Top 10 Hldgs %
29.51%
Holding
3,261
New
392
Increased
1,054
Reduced
1,061
Closed
327

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.38B
2
AAPL icon
Apple
AAPL
+$965M
3
MSFT icon
Microsoft
MSFT
+$832M
4
AMD icon
Advanced Micro Devices
AMD
+$565M
5
SHOP icon
Shopify
SHOP
+$446M

Sector Composition

Rank Sector Weight
1 Technology 27.66%
2 Financials 15.6%
3 Communication Services 9.14%
4 Consumer Discretionary 7.15%
5 Industrials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVCR icon
2576
NovoCure
NVCR
$1.73B
$2.66K ﹤0.01%
244
+192
+369% +$2.4K
PUBM icon
2577
PubMatic
PUBM
$585M
$2.66K ﹤0.01%
325
PRCT icon
2578
Procept Biorobotics
PRCT
$1.06B
$2.65K ﹤0.01%
+106
New +$2.99K
BCTX
2579
Briacell Therapeutics
BCTX
$29.9M
$2.64K ﹤0.01%
+802
New +$3.73K
SMCY
2580
YieldMax SMCI Option Income Strategy ETF
SMCY
$105M
$2.64K ﹤0.01%
482
+65
+16% +$494
BLND icon
2581
Blend Labs
BLND
$431M
$2.63K ﹤0.01%
1,550
EMF
2582
Templeton Emerging Markets Fund
EMF
$317M
$2.62K ﹤0.01%
150
ACVA icon
2583
ACV Auctions
ACVA
$1.31B
$2.62K ﹤0.01%
+619
New +$4.05K
VERX icon
2584
Vertex
VERX
$2.09B
$2.58K ﹤0.01%
+218
New +$3.4K
INVZ icon
2585
Innoviz Technologies
INVZ
$95M
$2.53K ﹤0.01%
4,000
TQQQ icon
2586
ProShares UltraPro QQQ
TQQQ
$32.1B
$2.5K ﹤0.01%
+60
New +$3K
PJP icon
2587
Invesco Pharmaceuticals ETF
PJP
$442M
$2.49K ﹤0.01%
24
RXST icon
2588
RxSight
RXST
$249M
$2.49K ﹤0.01%
405
NUVB icon
2589
Nuvation Bio
NUVB
$2.2B
$2.46K ﹤0.01%
+575
New +$3.2K
GENI icon
2590
Genius Sports
GENI
$1.85B
$2.43K ﹤0.01%
548
+160
+41% +$1.14K
BLFS icon
2591
BioLife Solutions
BLFS
$1.53B
$2.42K ﹤0.01%
+127
New +$2.81K
PMT
2592
PennyMac Mortgage Investment
PMT
$822M
$2.42K ﹤0.01%
208
-639
-75% -$7.88K
FLQM icon
2593
Franklin US Mid Cap Multifactor Index ETF
FLQM
$1.58B
$2.42K ﹤0.01%
+44
New +$2.51K
CATX icon
2594
Perspective Therapeutics
CATX
$332M
$2.41K ﹤0.01%
582
-73
-11% -$308
NORW icon
2595
Global X MSCI Norway ETF
NORW
$88M
$2.4K ﹤0.01%
63
XMHQ icon
2596
Invesco S&P MidCap Quality ETF
XMHQ
$5.47B
$2.38K ﹤0.01%
23
-18
-44% -$1.91K
ASAN icon
2597
Asana
ASAN
$1.92B
$2.37K ﹤0.01%
371
-12,419
-97% -$109K
IIF
2598
Morgan Stanley India Investment Fund
IIF
$217M
$2.36K ﹤0.01%
115
WGS icon
2599
GeneDx Holdings
WGS
$1.93B
$2.31K ﹤0.01%
36
-21,964
-100% -$2M
PDFS icon
2600
PDF Solutions
PDFS
$1.93B
$2.25K ﹤0.01%
+69
New +$2.25K

Similar funds

National Bank of Canada's Q1 2026 Portfolio in Review

As of Q1 2026, National Bank of Canada held 3,261 positions worth $112B, up 1.4% from $110B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

National Bank of Canada's Q1 2026 filing shows 392 new, 1,054 increased, 1,061 reduced and 327 closed positions. Its largest new stake was Revolution Medicines: 1,749,000 shares worth $170M. The largest sale was Meta Platforms (Facebook), an estimated $768M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Communication Services.

  • National Bank of Canada's largest Q1 2026 buy was Revolution Medicines: 1,749,000 shares worth $170M.
  • National Bank of Canada added most to NVIDIA in Q1 2026, an estimated $2.38B increase.
  • National Bank of Canada's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $768M.
  • National Bank of Canada fully exited Rexford Industrial Realty in Q1 2026, selling an estimated $81.2M.
  • National Bank of Canada's ten largest holdings make up 30% of its $112B portfolio in Q1 2026.
  • National Bank of Canada opened 392 new positions and closed 327 in Q1 2026.
  • National Bank of Canada's portfolio value rose 1.4% quarter-over-quarter to $112B.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.